Global Cardiac Defibrillators Market to Reach US$12.5 Billion by 2017, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Cardiac Defibrillators market. The global market for Cardiac Defibrillators is projected to reach US$12.5 billion by the year 2017. An aging global population and the rising incidence of various cardiovascular diseases are major driving factors for the global cardiac defibrillators market. Another major growth driver is the widespread availability of advanced medical services for patients suffering from sudden cardiac death.

Cardiac Defibrillators: A Global Strategic Business Report

Follow us on LinkedIn - Cardiovascular disease (CVD) is ranked among the leading causes of mortality across the world. The risk of sudden cardiac death is higher in patients suffering from coronary heart disease or arrhythmia. Survivors of sudden cardiac arrest are more likely to suffer from arrhythmic disorders such as bradycardia, tachycardia, and fibrillation, thereby necessitating the use of defibrillation technology. Defibrillation can prove to be life saving technique if employed within few minutes of a cardiac arrest. Growth in the Cardiac Defibrillators market is dependent on the pace of technological advancements and the level of competition. Rapid expansion in the number of care facilities, medical institutions, ambulatory trauma care services, hospitals, emergency care centers, and trauma care centers is contributing to the increased demand for cardiac defibrillators. Additionally, in several developed countries, defibrillators are being widely used in public places to provide defibrillation option for patients suffering from sudden cardiac arrest. However, in majority of the developing countries such as India, the concept of AEDs (automated external defibrillators) in public places is yet to take shape, as a result of which the potential opportunities in this segment are enormous.

As stated by the new market research report on Cardiac Defibrillators, the US continues to remain the single largest regional market driven by technological advancements and an aging population. The external defibrillators segment in the US is poised to grow further, propelled by the maturing manual external defibrillators market, and rise in demand for AEDs from both alternate care and public access segments. Expanding public access market is also expected to facilitate growth. The European market for external cardiac defibrillators is poised to register the fastest compounded annual growth rate of 9.9% over the analysis period, driven primarily by increase in out-of-hospital emergency services.

The Implantable/Internal Cardiac Defibrillators segment leads the cardiac defibrillators market devices market, while External Cardiac Defibrillators represent the faster growing segment with a CAGR of 8.8% over the analysis period. Growth of the external defibrillators market is facilitated by increased awareness in the US, development of the European and Japanese markets, and vast potential of under-penetrated markets of China, India, and the Eastern Bloc, among others. Additionally, technological advancements, increased use of defibrillators by emergency vehicles, and public access to AEDs (automatic external defibrillators) are expected to boost market prospects.

The global market for Implantable/Internal Cardiac Defibrillators (ICDs) is witnessing numerous technological advancements, enabling manufacturers to launch ICDs that offer superior rhythm management and address numerous rhythm disorders. ICDs are being used widely across Europe and the Americas, while the use of ICD therapies is expanding at a robust pace across Asia, particularly India, Japan and China. Though growth in the ICD market remained slow in the recent past owing to product recalls and adverse media publicity, the outlook remains positive due to a large under-penetrated patient population.

Major players profiled in the report include Biotronik GmbH & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, Defibtech LLC, GE Healthcare Ltd., HeartSine® Technologies Inc., Medtronic Inc., Nihon Kohden Corporation, Philips Healthcare, Sorin S.p.A, St. Jude Medical Inc., and Welch Allyn.

The research report titled "Cardiac Defibrillators: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (Units and US$ Million) for product segments Implantable/Internal Cardiac Defibrillators; and External Cardiac Defibrillators. Key markets analyzed for include the US and Rest of World for Implantable/Internal Cardiac Defibrillators; and US, Japan, Europe (France, Germany, Italy, UK and Rest of Europe), Asia-Pacific, Middle East, and Latin America for External Cardiac Defibrillators.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website